Trabectedin for recurrent WHO grade II or III meningioma: A randomized phase II study of the EORTC Brain Tumor Group (EORTC-1320-BTG) - Preusser, M; Le, Rhun E; Soffietti, R (J Clinl Oncol, 2019)
et al.